GENCARO BUCINDOLOL HCL Trademark

Trademark Overview

On Thursday, June 11, 2020, a trademark application was filed for GENCARO BUCINDOLOL HCL with the United States Patent and Trademark Office. The USPTO has given the GENCARO BUCINDOLOL HCL trademark a serial number of 88960902. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 15, 2024. This trademark is owned by ARCA Biopharma, Inc.. The GENCARO BUCINDOLOL HCL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations made in significant part of bucindolol hcl, for use in the treatment of diseases and disorders in the cardiovascular, vascular and hematology fields
gencaro bucindolol hcl

General Information

Serial Number88960902
Word MarkGENCARO BUCINDOLOL HCL
Filing DateThursday, June 11, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 20, 2020

Trademark Statements

Description of MarkThe mark consists of two intertwined curved lines inside of a stylized image of a heart with the words "GENCARO Bucindolol HCL" to the right. "GENCARO" is in bold font. Underneath is "Bucindolol HCL".
Goods and ServicesPharmaceutical preparations made in significant part of bucindolol hcl, for use in the treatment of diseases and disorders in the cardiovascular, vascular and hematology fields
Disclaimer with Predetermined Text"BUCINDOLOL HCL"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 9, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameARCA Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWestminster, CO 80020
Party NameARCA Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestminster, CO 80020

Trademark Events

Event DateEvent Description
Tuesday, January 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 15, 2024ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 14, 2023SOU EXTENSION 5 GRANTED
Monday, June 12, 2023SOU EXTENSION 5 FILED
Monday, June 12, 2023SOU TEAS EXTENSION RECEIVED
Saturday, December 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 15, 2022SOU EXTENSION 4 GRANTED
Thursday, December 15, 2022SOU EXTENSION 4 FILED
Thursday, December 15, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 15, 2022SOU EXTENSION 3 GRANTED
Wednesday, June 15, 2022SOU EXTENSION 3 FILED
Wednesday, June 15, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 28, 2021SOU EXTENSION 2 GRANTED
Wednesday, December 15, 2021SOU EXTENSION 2 FILED
Tuesday, December 28, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 15, 2021EMAIL RECEIVED
Thursday, June 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 15, 2021SOU EXTENSION 1 GRANTED
Tuesday, June 15, 2021SOU EXTENSION 1 FILED
Tuesday, June 15, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, April 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 28, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 20, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 30, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 16, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, September 16, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 16, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, September 16, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, September 14, 2020ASSIGNED TO EXAMINER
Friday, July 10, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, July 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 15, 2020NEW APPLICATION ENTERED

Related Keywords

bucindolol gencaro cardiovascular disorders vascular hematology fields diseases treatment made preparations significant